1. de Mulder, M, Cornel, J-H, van der Ploeg, T, et al. Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy. Am Heart Journal 2010; 160(3): 412–419.
Google Scholar | Crossref | Medline2. de Mulder, M, Umans, VA, Cornel, JH, et al. Intensive glucose regulation in hyperglycemic acute coronary syndrome. JAMA Internal Medicine 2013; 173(20): 1896–1904.
Google Scholar | Crossref | Medline3. van den Berg, VJ, Umans, VA, Stam, F, et al. Long-term follow-up of the randomized (BIOMArCS-2) glucose trial. Circulation 2016; 134(13): 984–986.
Google Scholar | Crossref | Medline4. Ruotolo, G, Båvenholm, P, Brismar, K, et al. Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment. J Am Coll Cardiol 2000; 35(3): 647–654.
Google Scholar | Crossref | Medline5. Grant, M, Wargovich, T, Ellis, E, et al. Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. a potential treatment for restenosis? Circulation 1994; 89(4): 1511–1517.
Google Scholar | Crossref | Medline6. Juul, A, Scheike, T, Davidsen, M, et al. Low serum insulin-like growth factor i is associated with increased risk of ischemic heart disease. Circulation 2002; 106(8): 939–944.
Google Scholar | Crossref | Medline | ISI7. Spallarossa, P, Brunelli, C, Minuto, F, et al. Insulin-like growth factor-1 and angiographically documented coronary artery disease. Am J Cardiol 1996; 77(2): 200–202.
Google Scholar | Crossref | Medline | ISI8. Laughlin, GA, Barrett-Connor, E, Criqui, MH, et al. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab 2004; 89(1): 114–120.
Google Scholar | Crossref | Medline9. Janssen, J, Stolk, R, Pols, H, et al. Serum total IGF-I, Free IGF-I, and IGFBP-1 levels in an elderly population. Arteriosclerosis, Thrombosis, Vascular Biology 1998; 18(2): 277–282.
Google Scholar | Crossref | Medline | ISI10. Ezzat, VA, Duncan, ER, Wheatcroft, SB, et al. The role of IGF-I and its binding proteins in the development of type 2 diabetes and cardiovascular disease. Diabetes Obes Metab 2008; 10(3): 198–211.
Google Scholar | Crossref | Medline | ISI11. Chao, W, Matsui, T, Novikov, MS, et al. Strategic advantages of insulin-like growth factor-I expression for cardioprotection. Journal Gene Medicine 2003; 5(4): 277–286.
Google Scholar | Crossref | Medline12. Yamaguchi, H, Komamura, K, Choraku, M, et al. Impact of serum insulin-like growth factor-1 on early prognosis in acute myocardial infarction. Intern Med 2008; 47(9): 819–825.
Google Scholar | Crossref | Medline | ISI13. Friberg, L., Werner, S, Eggertsen, G, et al. Growth hormone and insulin-like growth factor-1 in acute myocardial infarction. Eur Heart J 2000; 21(18): 1547–1554.
Google Scholar | Crossref | Medline | ISI14. Bourron, O, Le Bouc, Y, Berard, L, et al. Impact of age-adjusted insulin-like growth factor 1 on major cardiovascular events after acute myocardial infarction: results from the fast-mi registry. J Clin Endocrinol Metab 2015; 100(5): 1879–1886.
Google Scholar | Crossref | Medline15. Lewitt, MS . Role of the insulin-like growth factors in the endocrine control of glucose homeostasis. Diabetes Res Clin Pract 1994; 23(1): 3–15.
Google Scholar | Crossref | Medline16. Sandhu, MS, Heald, AH, Gibson, JM, et al. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. The Lancet 2002; 359(9319): 1740–1745.
Google Scholar | Crossref | Medline17. Wallander, M, Brismar, K, Öhrvik, J, et al. Insulin-like growth factor I: a predictor of long-term glucose abnormalities in patients with acute myocardial infarction. Diabetologia 2006; 49(10): 2247–2255.
Google Scholar | Crossref | Medline18. Teppala, S, Shankar, A. Association between serum IGF-1 and diabetes among U.S. adults. Diabetes Care 2010; 33(10): 2257–2259.
Google Scholar | Crossref | Medline19. de Mulder, M, Umans, V, Stam, F, et al. Intensive management of hyperglycaemia in acute coronary syndromes. study design and rationale of the BIOMArCS 2 glucose trial. Diabetic Med 2011; 28(10): 1168–1175.
Google Scholar | Crossref | Medline20. Thygesen, K, Alpert, JS, Jaffe, AS, et al. Fourth universal definition of myocardial infarction (2018). European Heart Journal, 2018. ehy462-ehy.
Google Scholar21. Organization WH . Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO/IDF Consultation. Geneva, Switzerland: WHO Press, 2006.
Google Scholar22. Association AD . 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2019. Diabetes Care 2019; 42(Suppl 1): S13–S28.
Google Scholar | Crossref | Medline23. Wallander, M, Norhammar, A, Malmberg, K, et al. Insulin-like growth factor binding protein 1 predicts cardiovascular morbidity and mortality in patients with acute myocardial infarction and type 2 diabetes. Diabetes Care 2007; 30(9): 2343–2348.
Google Scholar | Crossref | Medline24. Gajarsa, JJ, Kloner, RA. Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Failure Reviews 2011; 16(1): 13–21.
Google Scholar | Crossref | Medline | ISI25. Yang, W, Zhang, F, Tang, H, et al. Summed thickening score by myocardial perfusion imaging: a risk factor of left ventricular remodeling in patients with myocardial infarction. J Nucl Cardiol 2018; 25: 742–753.
Google Scholar | Crossref | Medline26. Lee, W-L, Chen, J-W, Ting, C-T, et al. Changes of the insulin-like growth factor I system during acute myocardial infarction: implications on left ventricular remodeling. J Clin Endocrinol Metab 1999; 84(5): 1575–1581.
Google Scholar | Medline | ISI27. Henneman, MM, Chen, J, Ypenburg, C, et al. Phase analysis of gated myocardial perfusion single-photon emission computed tomography compared with tissue Doppler imaging for the assessment of left ventricular dyssynchrony. J Am Coll Cardiol 2007; 49(16): 1708–1714.
Google Scholar | Crossref | Medline28. Shabana, A, El-Menyar, A. Myocardial Viability: What We Knew and what Is New. Cardiology Research and Practice 2012; 2012: 607486.
Google Scholar29. Bronisz, A, Kozinski, M, Magielski, P, et al. Value of oral glucose tolerance test in the acute phase of myocardial infarction. Cardiovasc Diabetology 2011; 10(1): 21.
Google Scholar | Crossref | Medline30. Knudsen, EC, Seljeflot, I, Abdelnoor, M, et al. Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients. Cardiovasc Diabetology 2009; 8(1): 6.
Google Scholar | Crossref | Medline31. de Mulder, M, Oemrawsingh, RM, Stam, F, et al. Comparison of diagnostic criteria to detect undiagnosed diabetes in hyperglycaemic patients with acute coronary syndrome. Heart 2012; 98(1): 37–41.
Google Scholar | Crossref | Medline32. Norhammar, A, Tenerz, Å, Nilsson, G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. The Lancet 2002; 359(9324): 2140–2144.
Google Scholar | Crossref | Medline | ISI33. Wallander, M, Malmberg, K, Norhammar, A, et al. Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice: a report on repeated oral glucose tolerance tests from the GAMI study. Diabetes Care 2008; 31(1): 36–38.
Google Scholar | Crossref | Medline | ISI34. Ye, Y, Xie, H, Zhao, X, et al. The oral glucose tolerance test for the diagnosis of diabetes mellitus in patients during acute coronary syndrome hospitalization: a meta-analysis of diagnostic test accuracy. Cardiovasc Diabetology 2012; 11(1): 155.
Google Scholar | Crossref | Medline35. Tamita, K, Katayama, M, Takagi, T, et al. Newly diagnosed glucose intolerance and prognosis after acute myocardial infarction: comparison of post-challenge versus fasting glucose concentrations. Heart 2012; 98(11): 848–854.
Google Scholar | Crossref | Medline